The approaches of molecular and cellular biology have been rewarding in relating structure and function at the molecular level to the behavior of the intact cell, either alone or as part of organ systems in the multi-cellular organism. This multi-disciplinary approach is a requisite for a comprehensive understanding of hematopoietic and vascular cell function. This competitive renewal application. This competitive renewal application for a Training Grant in Hematopoietic and vascular cell function reflects the presence in the Jefferson Cancer Institute of selected, accomplished scientists who share related interests in defining the normal mechanisms of cellular function and growth and their derangement in disease processes. Predoctoral students must compete a rigorous series of graduate cores giving them a thorough background in biochemistry, molecular biology and cell biology. This didactic curriculum is then followed by a more specialized courses within each Ph.D. Program. Students also present a series of seminars to the faculty and are required to complete three rotations in the laboratories of research preceptors with diverse interests. Research training is actually supervised by the Research Advisory Committee. Ph.D. students will have research training opportunities in the following research areas: 1) Role of oncogenes and tumor suppressor genes in the regulation of normal hematopoiesis and in leukemogenesis; 2) Role of the insulin like growth-factor-1 (IGF-1) receptor in the control of cell survival and differentiation in hematopoietic cells; 3) Role of chromosomal rearrangements in the pathogenesis of human hematopoietic malignancies and identification of genes involved in normal and malignant hematopoiesis; 4) Erythropoietin function and gene expression in erythroid differentiation. 5) Biology of Natural Killer (NK) cells; 8) Role of the blood coagulation factor XI; 9) Structure-function relation in platelet factor-4 and B-thromboglobulin and platelet cell adhesion; 10) Regulation of platelet function; 11) Structure and function of endothelial glycoprotein Ib complex. The objective of this research training is to develop competent research scientists capable of performing and eventually directing research with a comprehensive approach in the area of cell function.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007780-10
Application #
6627445
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F1))
Program Officer
Chang, Henry
Project Start
1994-07-01
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2005-06-30
Support Year
10
Fiscal Year
2003
Total Cost
$103,504
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
053284659
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Cantor, Joshua P; Iliopoulos, Dimitrios; Rao, Atul S et al. (2007) Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity. Int J Cancer 120:24-31
Semba, Shuho; Han, Shuang-Yin; Qin, Haiyan R et al. (2006) Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 281:28244-53
Semba, S; Trapasso, F; Fabbri, M et al. (2006) Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential. Oncogene 25:2860-72
Wermuth, Peter J; Buchberg, Arthur M (2005) Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines. Blood 105:1222-30
Iliopoulos, Dimitrios; Guler, Gulnur; Han, Shuang-Yin et al. (2005) Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 24:1625-33
Ottey, M; Han, S-Y; Druck, T et al. (2004) Fhit-deficient normal and cancer cells are mitomycin C and UVC resistant. Br J Cancer 91:1669-77
Tungaturthi, Parithosh K; Sawaya, Bassel E; Ayyavoo, Velpandi et al. (2004) HIV-1 Vpr: genetic diversity and functional features from the perspective of structure. DNA Cell Biol 23:207-22
Tungaturthi, Parithosh K; Sawaya, Bassel E; Singh, Satya P et al. (2003) Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. Biomed Pharmacother 57:20-4
Powzaniuk, M A; Trotta, R; Loza, M J et al. (2001) B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells. J Immunol 167:242-9
Bagella, L; MacLachlan, T K; Buono, R J et al. (1998) Cloning of murine CDK9/PITALRE and its tissue-specific expression in development. J Cell Physiol 177:206-13

Showing the most recent 10 out of 16 publications